Category: Latest News
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Inflation Data, Micron Outlook and BoE Decision Set the Tone for Markets
U.S. equity futures were mostly higher on Thursday, supported by upbeat guidance from semiconductor group Micron (NASDAQ:MU), although investor sentiment remains sensitive ahead of the release of key U.S. inflation figures. In Europe, several central banks are holding policy meetings, with the Bank of England expected to stand out as the only one to cut…
-
U.S. Stocks Move Sharply Lower Amid Renewed Tech Weakness
After ending yesterday’s choppy session narrowly mixed, stocks moved to the upside in early trading on Wednesday but quickly came under pressure. The major averages pulled back well off their highs of the session and firmly into negative territory. The major averages saw further downside going into the end of the day, closing just off…
-
Inspirato Shares Surge on $59 Million Takeover Agreement
Shares of Inspirato Inc. (NASDAQ:ISPO) jumped 46.5% in premarket trading on Wednesday after the luxury vacation club announced it had agreed to be acquired by Exclusive Investments LLC in an all-cash deal priced at $4.27 per share. The transaction values Inspirato at roughly $59 million on a fully diluted basis and represents a premium of…
-
CNS Pharmaceuticals Shares Dip After CEO Departure Announcement
Shares of CNS Pharmaceuticals Inc. (NASDAQ:CNSP) slipped 2.8% on Wednesday after the company disclosed that its Chief Executive Officer, John Climaco, has stepped down from the role. The biopharmaceutical firm, which develops therapies targeting primary and metastatic cancers of the brain and central nervous system, announced that Rami Levin has been appointed President and Chief…
-
DEFSEC Shares Slide Following Announcement of Equity Offering
Shares of DEFSEC Technologies Inc. (NASDAQ:DFSC) dropped 17.7% on Wednesday after the cybersecurity company revealed plans for a registered direct share offering alongside a concurrent private placement involving shares and warrants. Under the terms of the transaction, DEFSEC intends to issue 566,040 common shares at a price of CAD$3.64 (US$2.65) per share through the registered…
-
Processa Pharmaceuticals Shares Surge on Encouraging Cancer Trial Update
Shares of Processa Pharmaceuticals Inc. (NASDAQ:PCSA) jumped 23.8% on Wednesday after the company reported early Phase 2 clinical data indicating that its Next Generation Cancer (NGC) therapy achieved higher exposure to cancer-fighting metabolites while maintaining a safety profile comparable to existing treatments. The clinical-stage biotech company said results from 16 of the 19 patients enrolled…
-
Vistagen Shares Collapse After Phase 3 Anxiety Drug Trial Misses Goal
Shares of Vistagen (NASDAQ:VTGN) plunged 78.8% on Wednesday after the biopharmaceutical company disclosed that its Phase 3 clinical trial of fasedienol for social anxiety disorder failed to achieve its primary endpoint. The late-stage drug developer said the PALISADE-3 study did not show a statistically meaningful reduction in anxiety symptoms compared with placebo. Results indicated a…
-
Moleculin Biotech Shares Slide After Release of Pediatric Brain Tumor Trial Data
Moleculin Biotech Inc. (NASDAQ:MBRX) shares fell 9.1% in premarket trading on Wednesday after the company disclosed results from a Phase 1 clinical study evaluating its drug candidate WP1066 in pediatric patients with brain tumors. The study, sponsored by Emory University and carried out at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of…
-
Compugen Shares Jump After $65 Million Royalty Monetization Deal With AstraZeneca
Shares of Compugen Ltd. (NASDAQ:CGEN) rose 12.8% in premarket trading on Wednesday after the company unveiled a strategic agreement with AstraZeneca to monetize part of its future royalty stream tied to the cancer therapy rilvegostomig. Under the non-dilutive arrangement, Compugen will receive an upfront payment of $65 million, with the potential to earn an additional…
-
Toro Shares Climb After Earnings Beat and Upgraded 2026 Outlook
Shares of The Toro Company (NYSE:TTC) rose 3.2% in premarket trading on Wednesday after the outdoor power equipment maker delivered fourth-quarter results that topped expectations and issued an upbeat forecast for fiscal 2026. Toro reported adjusted earnings of $0.91 per share for the fourth quarter, slightly ahead of analyst estimates of $0.90. Quarterly revenue totaled…